Kathleen D. Scott

Date	Company	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
6 Dec 24	NKGN NKGen Biotech, Inc. Common Stock	Stock Option Common Stock	Grant	Acquire A	No	No	0.438	500,000	219.00 k	500,000
6 Dec 24	NKGN NKGen Biotech, Inc. Common Stock	Stock Option Common Stock	Grant	Acquire A	No	No	1.62	300,000	486.00 k	300,000
16 Oct 24	SPRY ARS Pharmaceuticals	Common Stock	Sell	Dispose S	No	Yes	16	12,500	200.00 k	4,949
16 Oct 24	SPRY ARS Pharmaceuticals	Common Stock	Option exercise	Acquire M	No	No	1.5	12,500	18.75 k	17,449
16 Oct 24	SPRY ARS Pharmaceuticals	Stock Option Common Stock	Option exercise	Dispose M	No	No	1.5	12,500	18.75 k	802,330
20 Aug 24	SPRY ARS Pharmaceuticals	Common Stock	Sell	Dispose S	No	Yes	16	12,500	200.00 k	13,199
20 Aug 24	SPRY ARS Pharmaceuticals	Common Stock	Option exercise	Acquire M	No	No	1.5	12,500	18.75 k	25,699
20 Aug 24	SPRY ARS Pharmaceuticals	Stock Option Common Stock	Option exercise	Dispose M	No	No	1.5	12,500	18.75 k	814,830
12 Feb 24	NKGN NKGen Biotech, Inc. Common Stock	Stock Option Common Stock	Grant	Acquire A	No	No	1.62	300,000	486.00 k	300,000
4 Jan 24	DRMA Dermata Therapeutics	Stock Option Common Stock	Grant	Acquire A	No	No	0.6099	10,000	6.10 k	10,000

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.